ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
Authors:
- Salvador Domènech-MontoliuSDSalvador Domènech-Montoliu
- Joan Puig-BarberàJoan Puig-Barberà
- Maria Rosario Pac-SaMPMaria Rosario Pac-Sa
- Paula Vidal-UtrillasPVPaula Vidal-Utrillas
- Marta Latorre-PovedaMLMarta Latorre-Poveda
- Alba Del Rio-GonzálezARAlba Del Rio-González
- Sara Ferrando-RubertSFSara Ferrando-Rubert
- Gema Ferrer-AbadGFGema Ferrer-Abad
- Manuel Sánchez-UrbanoManuel Sánchez-Urbano
- Laura Aparisi-EsteveLALaura Aparisi-Esteve
- Gema Badenes-MarquesGBGema Badenes-Marques
- Belén Cervera-FerrerBCBelén Cervera-Ferrer
Open Access
- 24 September 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (19) , 10039
Abstract
After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results.Keywords
This publication has 65 references indexed in Scilit:
- Association between ABO blood groups and risk of SARS‐CoV‐2 pneumoniaBritish Journal of Haematology, 2020
- Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2PLOS Pathogens, 2020
- ABO blood group predisposes to COVID-19 severity and cardiovascular diseasesEuropean Journal of Preventive Cardiology, 2020
- Genetically Determined ABO Blood Group and its Associations With Health and DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2020
- Position of human blood group O(H) and phenotype‐determining enzymes in growth and infectious diseaseAnnals of the New York Academy of Sciences, 2018
- Influence of ABO blood group on sports performanceAnnals of Translational Medicine, 2017
- Robust causal inference using directed acyclic graphs: the R package ‘dagitty’International Journal of Epidemiology, 2017
- Marginal Structural Models and Causal Inference in EpidemiologyEpidemiology, 2000
- Causal Diagrams for Epidemiologic ResearchEpidemiology, 1999
- The gel test: a new way to detect red cell antigen‐antibody reactionsTransfusion, 1990